Resources: BPC-157 FAQ What is BPC-157
Follistatin represents one of the earliest documented types of gene doping that seeks to replicate follistatin and in so doing biologically inhibit myostatin and enhance muscle growth
DSIP and Narcolepsy Research The available evidence is too limited to establish DSIP as a narcolepsy treatment
Baseline inflammatory markers, including C-reactive protein and interleukin-6, can provide an objective reference point for assessing systemic anti-inflammatory effects where that is a stated goal
Medical Disclaimer The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment
MYCN abundance modestly influenced sensitivity: MYCN downregulation in IMR-5/75 cells slightly reduced toxicity, while MYCN induction in SH-SY5Y/MYCN slightly increased it, though neither change reached significance